2016-10-20T01-26-57Z
Source: International Journal of Advances in Medicine
Hiremath M. S., C. N. Makhale, Abhishek Gorlawar, Ashish Indani, Poonam Bhutada, Murlidhar Bendale.
Background: The study aimed to assess the immediate (procedural outcome) and long- term clinical (Cumulative hierarchical MACE up to 2 years) and angiographic outcomes (late lumen loss at 8 months) in the patients undergoing angioplasty with at least one 40 mm GenXSync SES. (Indian Study Regulatory ID CTRI/2014/07/004783). Methods: This single centre prospective study included 26 real-world coronary artery disease (CAD) patients with long and very long lesions (38 lesions, 48 stents). All patients were treated with one or more 40 mm GenxSync sirolimus eluting stent (SES). All the subjects were followed up for 2 years including angiographic follow-up at 8 months. Angiography data was evaluated and reported by an independent angiographic core-lab. Subset analyses were performed for all 40mm long stents and 40mm with small diameter stents. Results: The procedural success was observed in 94%. The acute gain was 2.25±0.53mm in stent and 2.09±0.71mm in segment despite of long and complex lesions including CTO. At 2 years, there was only 1 (3.84%) MACE (binary restenosis at 8 months) and stent thrombosis. At 8 months late lumen loss was in-segment 0.15±0.30mm and in-stent 0.14±0.17mm (p = 0.06). The 40mm stents subset, revealed acute gain of 2.21±0.58mm in-stent and 2.01±0.74mm in-segment. The late loss was 0.16± 0.31mm and 0.13±0.17mm in-stent and in-segment respectively. In 40mm stent with small diameter subset, the acute gain was 2.19±0.42mm in-stent and 1.69 ± 0.59mm in-segment and late lumen loss was 0.10±0.18mm in-segment and 0.13± 0.33mm in-stent. Conclusions: The results of real world long lesions PCI revealed efficacy, safety and procedural success observed with GenXSync stent comparable to other reported studies.
http://ift.tt/2evd0cA
Πέμπτη 20 Οκτωβρίου 2016
Real world experience of GenXSync sirolimus eluting coronary stent system in patients with long coronary lesions: outcome of the GEL registry
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Women in Love by . Lawrence. Searchable etext. Discuss with other readers. from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Ino...
-
Dracaena cochinchinensis Lour. is an ethnomedicinally important plant used in traditional Chinese medicine known as dragon’s blood. Excessiv...
-
IJMS, Vol. 18, Pages 1603: Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indic...
-
by Huiyuan Zhu, Lian Zhang, Yali Wang, Preeti Hamal, Xiaofang You, Haixia Mao, Fei Li, Xiwen Sun The aim of this study was to assess whethe...
-
Abstract Combating gliomagenic global immunosuppression is the one of the emerging key for improving prognosis in malignant glioma. Apopt...
-
<span class="paragraphSection"><div class="boxTitle">Abstract</div><div class="boxTitle"...
-
by Emily M. Zygiel, Karen A. Noren, Marta A. Adamkiewicz, Richard J. Aprile, Heather K. Bowditch, Christine L. Carroll, Maria Abigail S. Cer...
-
A guide to nursing education. Includes a directory of nursing schools, nursing programs, nursing colleges and online nursing degrees. from...
-
Purpose People with type 2 diabetes (T2D) have a doubled morbidity and mortality risk compared with persons with normal glucose tolerance. D...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου